These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-001010-13 Escitalopram til behandling af smerter ved polyneuropati not-yet-due
Completed, report not yet due 2004-001347-29 Treatment of patients with locally advanced rectal cancer. TEGAFOX (UFT/leukovorin og Oxaliplatin) before, during and after curatively intended radiotherapy. A Danish phase I/II trial 2009-05-07 not-yet-due
Ongoing 2004-002653-31 CAPHI. Profylactic effect of Ca2+ sensitizer versus phosphodiesterase inhibitor infusion at CAGB patients with preoperative low ejection fraction. A prospective randomised clinical trial. not-yet-due
Not reported 2004-005164-25 Phase II study of thalidomide in combination with temozolomide in metastatic malignant melanoma with brain metastases 2007-12-04 due-trials
Not reported 2004-005166-20 Phase II study of first-line therapy with Thalidomide in combination with Peg-introna and decrescendo IL-2 in patients with metastatic malignant melanoma 2008-01-02 due-trials
Not reported 2005-001078-29 Effekten af forbehandling med 0.1 mg rekombinant human TSH (rhTSH) på glandula thyreoidea’s 131I-optagelse og graden af strumareduktion efter 131I-behandling, hos patienter med atoksisk multinodøs str... 2010-01-25 due-trials
Completed, but no date 2005-001191-12 Forebyggelse af inkompenseret levercirrose med Losartan Et prospektivt randomiseret dobbeltblindet lantidsstudie bad-data
Ongoing 2005-001930-34 Left ventricular reverse remodelling after aortic valve replacement in severe valvular aortic stenosis - effect of blockade of the angiotensin-II receptor not-yet-due
Not reported 2005-003046-33 Double-bllind, randomised, placebo-controlled trial of levetiracetam in painful polyneuropathy 2008-10-02 due-trials
Ongoing 2005-003104-11 Androgen priming in the late luteal phase as a mean to improve the outcome of ovarian stimulation for IVF in normogonadotrophic women with a previously proven poor response not-yet-due
Ongoing 2005-004082-42 The Pharmacogenetics of Oxycodone analgesia in human experimental pain models not-yet-due
Not reported 2006-000397-71 Double-blind, randomised, placebo-controlled trial of levetiracetam for central neuropathic pain in patients with multiple sclerosis 2009-01-12 due-trials
Not reported 2006-001976-19 “Betydningen af CYP2C19 polymorfi for escitaloprams farmakokinetik og farmakodynamik, målt som ændringer i pupildiameter” 2007-10-22 due-trials
Completed, report not yet due 2006-002270-21 Phase I/II study of Taxotere® (docetaxel), Eloxatin® (oxaliplatin) and Xeloda® (capecitabine) as first line treatment to patients with non-resectable ventricular cancer and/or distal esophageal cancer 2013-09-10 not-yet-due
Not reported 2006-004763-57 Et ikke blindet randomiseret forsøg på effekten af metformin vs. metformin og p-piller vs. p-piller på glukosetolerance, insulinresistens, væksthormon og cortisol metabolisme ved polycystisk ovarie... 2013-09-01 due-trials
Not reported 2007-001690-28 Odense Androgen Study - The effect of Testim vs strength training i a populationbased, randomised, placebocontrolled, doubleblinded study in hypogonadal men 2009-09-20 due-trials
Completed, but no date 2007-004232-22 Phase II study with cetuximab, irinotecan and sunitinib (CIS) for patients with treatment resistant colorectal cancer bad-data
Not reported 2007-004470-10 "Effekten af escitalopram på tramdadols farmakokinetik og farmakodynamik" 2008-08-21 due-trials
Completed, but no date 2007-005631-29 Cannabinoid CB1 receptor agonist treatment in severe chronic anorexia nervosa bad-data
Not reported 2007-005835-27 Local Infiltration with Ropivacaine for Postoperative Analgesia after Hip Fracture 2011-05-01 due-trials
Not reported 2007-007275-16 Antibiotic treatment in patients hospitalized with an acute exacerbation in chronic obstructive pulmonary disease. Effect of one day of antibiotic treatment compared t0 6 days of antibiotic treatment ... 2010-06-10 due-trials
Ongoing 2007-007834-21 FLOX + Erbitux, 1a linjens-behandling till patienter med metastaserende kolorektalcancer och wild type K-RAS tumor not-yet-due
Not reported 2008-000796-17 Optagelse af svampemidlet miconazol og effekt på østrogenmetaboliserende enzymer i mennesker 2008-08-11 due-trials
Completed, but no date 2008-001678-34 Examination of the efficacy of glycerol, two topical steroids and a topical immune modulator in experimentally induced skin irritation bad-data
Not reported 2008-006168-12 Phase II trial with Cetuximab and Irinotecan (CetIri) for patients with platinum resistant esofagus- or gastric cancer 2013-10-25 due-trials
Ongoing 2008-006438-82 Vitamin D og kronisk nyreinsufficiens not-yet-due
Not reported 2008-008919-26 Postoperative Analgesia With Local Infiltration After Periacetabular Osteotomy For The Treatment Of Dysplasia 2011-05-01 due-trials
Not reported 2008-008920-34 Induction chemotherapy with Carboplatin and Navelbine Oral® followed by concomitant Navelbine Oral® and irradiation in local-regionally advanced non-small cell lung cancer. A randomized phase II stud... 2017-07-21 due-trials
Not reported 2008-008921-30 Concomitant Tarceva® and irradiation in patients in local-regionally advanced non-small cell lung cancer. A phase II study 2017-02-04 due-trials
Completed, but no date 2009-010058-37 Chronic subdural hematome - reduction of risc of recurrence by treatment with ACE inhibitors (in Danish: Kronisk subduralt hæmatom – reduktion af recidiv risiko ved behandling med ACE hæmmere) bad-data
Completed, but no date 2009-013396-22 Serumkoncentrationsstudie bad-data
Completed, but no date 2009-013642-80 Randomised, double-blind, placebo-controlled trial of the effect of the combination of imipramine and pregabalin for the treatment of painful polyneuropathy bad-data
Completed, but no date 2009-013878-40 Phase II trial of Cetuximab in combination with chemotherapy (Carboplatinum and Navelbine) for patients with platinum-resistant head- and neckcancer bad-data
Not reported 2009-014407-31 Randomiseret fase II forsøg med irinotecan, cetuximab og everolimus (ICE) sammenlignet med capecitabin og oxaliplatin (CapOx) til patienter med gemcitabin resistent pancreascancer. 2012-12-15 due-trials
Ongoing 2009-014691-21 GAND-emesis A multinational, randomized, double-blind, placebo-controlled, parallel-group study to investigate the efficacy and tolerability of palonosetron and dexamethasone plus the neurokinin1-rece... not-yet-due
Not reported 2009-016591-68 Placebo-controlled trial investigating the effect of Vitamin K3-lotion for the treatment of cetuximab induced folliculitis 2012-07-31 due-trials
Not reported 2009-017033-22 Syd Dansk Hypertensions- og Diabetes Studie 2012-05-30 due-trials
Completed, but no date 2009-017642-32 Nyreprofylakse ved ST-segment elevation myokardie infarkt og primær PCI bad-data
Completed, but no date 2010-021016-41 Dose determination of Taxotere®, Eloxatin® and Xeloda® (TEX) in combination with Herpectin® as first line treatment to patients with HER2-positive non-resectable esophagus, cardia or gastric cancer bad-data
Completed, but no date, and reported results 2010-022034-88 Evaluation of the optimal dose of prophylactic anticoagulation with low- molecular- weight heparin administered subcutaneously to critically ill patients – part 2 bad-data
Not reported 2010-022319-20 The effect of antidepressant therapy on quality of life, physical and menthal health and cortisole metabolism in PCOS. 2015-06-30 due-trials
Completed, but no date, and reported results 2010-022604-45 EFFEKTEN AF EZETIMIBE SOM TILLÆG TIL OPTIMAL STATINBEHANDLING PÅ PLAQUE-KOMPOSITIONEN HOS PATIENTER MED AKUT MYOKARDIEINFARKT - VURDERET MED OPTICAL COHERENCE TOMOGRAPHY OG INTRAVASKULÆR ULTRALYD (OCT... bad-data
Not reported 2010-023331-42 Oxcarbazepine for the treatment of chronic peripheral neuropathic pain: predictors of response - a randomised, double-blind, placebo-controlled clinical trial 2013-07-31 due-trials
Ongoing 2011-000703-40 Clinical trial with chemotherapy for patients with non-resectable, locally advanced pancreatic cancer and addition of chemo-radiotherapy for patients with borderline resectable pancreatic cancer. not-yet-due
Ongoing 2011-002243-98 The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity not-yet-due
Ongoing 2011-004188-65 FOLFIRI + Erbitux versus alternating FOLFIRI + Erbitux/FOLFOX + Erbitux to patients with RAS wild type metastatic colorectalcancer not-yet-due
Completed, but no date 2011-004268-31 Adalimumab (Humira) in the treatment of chronic pouchitis bad-data
Ongoing 2012-000266-38 Targeted radionuclide therapy of neuroendocrine tumours using 177Lu-DOTATATE combined with induced local tumour up-regulation of somatostatin receptor expression for increased tumour dosage and tumour... not-yet-due
Completed, but no date 2012-001557-46 Perioperativ installation of ropivacain in mastectomy – with or without axillary lymph node dissection after sentinel node diagnostics or known lymph node metastasis – A double-blind, randomized clini... bad-data
Completed, report not yet due 2012-002275-33 Renal and cardiac effects of terlipressin and dobutamin in cirrhosis and ascites. A randomised study. 2018-05-24 not-yet-due
Not reported 2012-002321-30 Randomized phase II trial with irinotecan as monotherapy compared to irinotecan and bevacizumab (BevIri) for patietns with platinum resistant non-resectable esophagus-, cardia or gastric cancer 2016-05-02 due-trials
Not reported 2012-002327-15 Phase II study with temozolomide and capecitabine for patients with refractory colorectal cancer 2016-09-21 due-trials
Ongoing 2012-002702-51 Discontinuation of infliximab therapy in patients with Crohn’s disease during sustained complete remission: not-yet-due
Not reported 2012-003077-26 Topical lidocaine for the treatment of focal peripheral neuropathic pain: response in relation to pain phenotype 2014-03-14 due-trials
Completed, but no date, and reported results 2012-004368-23 Feasible strategy for preventing blood clots in critically ill patients with acute kidney Injury bad-data
Completed, but no date 2012-004436-36 A prospective pilotstudy of immunological and radiological effects of intrathecal rituximab in patients with secondary progressive multiple sclerosis bad-data
Not reported 2013-000235-27 Interscalener blockade for surgery on the shoulder, a comparison of two dosing regimens: Fixed intermittent bolus with the possibility of PCA (Patient controlled administration) Vs. continuous infusio... 2015-03-22 due-trials
Not reported 2013-000797-30 Inhibition of aldosterone to diminish diffuse myocardial fibrosis in atrial fibrillation 2017-03-26 due-trials
Ongoing 2013-001409-10 FATIMS - Fampyra and T cell Immunity in Multiple Sclerosis; a study of the Fampyra induced immunomodulatory T cell responses in MS not-yet-due
Ongoing 2013-001648-79 Epirubicin as 2nd line treatment to patients with TOP2A gene amplified and oxaliplatin refractory metastatic colerectal cancer not-yet-due
Completed, but no date 2013-001807-35 Imaging with 111In-Octreotide SPECT-CT compared to 68Ga-DOTATATE PET-CT in patients admitted for evaluation of GastroEnteroPancreatic NeuroEndocrine Tumours, GEP-NETs bad-data
Not reported 2013-002217-36 Crystalloid versus colloid for goal directed haemodynamic optimisation in major abdominal cancer surgery. 2015-06-30 due-trials
Ongoing 2013-003304-39 Assisted reproduction and the early luteal phase not-yet-due
Ongoing 2013-004629-96 Diagnostic Modalities in Nuclear Medicine in Well-Differentiated Thyroid Cancer not-yet-due
Ongoing 2013-004886-14 MET-PET-study - Comparative study of Tc-99m- sestamibi SPECT/ldCT with C-11-L-Methionin PET/diagnostic CT and theri ability to locate paratyroid adenomas preoperatively. not-yet-due
Ongoing 2014-000348-14 Statin-treatment and peripheral neuropathy - a randomized clinical trial not-yet-due
Ongoing 2014-000394-39 Full dose monotherapy S-1 (followed by irinotecan) compared to reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic color... not-yet-due
Reported results 2014-000826-39 Determining the tissue concentration of dicloxacillin using Microdialysis (on healthy male subjects) 2015-01-30 due-trials
Not reported 2014-001299-79 Pneumococcal vaccination of rheumatoid arthritis patients in immunomodulatory therapy 2017-06-19 due-trials
Not reported 2014-002124-27 GLP-1 Agonist and Bone: Effects of Exenatide on Bone Metabolism 2017-09-11 due-trials
Ongoing 2014-002494-12 Magnolia Study Prolonged Protection from Bone Disease in Multiple Myeloma. An open label phase 3 multicenter international randomised trial not-yet-due
Ongoing 2014-002798-12 Neoadjuvant chemotherapy in patients with biliary tract carcinomas - A Nordic phase II study not-yet-due
Reported results 2014-003466-25 Randomized, double-blind, prospective, placebo-controlled trial of the effect of intravenous lidocaine infusion for postoperative pain management and bowel function in robot assisted laparoscopic colo... 2017-05-01 due-trials
Not reported 2014-004357-13 Coagaulation in patients with atrial fibrillation: The effect of dabigatran 2016-06-14 due-trials
Ongoing 2014-004729-42 The effect of testosterone replacement in patients with hypogonadotroph hypogonadism due to opioid treatment for non-malignant disease not-yet-due
Not reported 2014-004740-35 Loperamide vs. Placebo's effect on ileostomy output: A clincal randomized patientblinded crossover study 2015-07-10 due-trials
Not reported 2014-005589-31 4 Week treatment for Injecting Drug Users with chronic hepatitis C 2016-12-31 due-trials
Completed, report not yet due 2015-002294-38 DANSAC-open: A multicenter, open label study to investigate the efficacy and tolerability of olanzapine in patients with advanced cancer not receiving chemotherapy or irradiation. 2018-09-05 not-yet-due
Ongoing 2015-002984-40 The beta-2-agonist terbutaline for the treatment of painful polyneuropathy. A randomised, active- and placebo-controlled trial not-yet-due
Completed, but no date, and reported results 2015-003070-33 DANSAC-RCT: Fosaprepitant in patients with advanced cancer not receiving chemotherapy or irradiation; A multicenter, randomized, double-blind, placebo-controlled study. bad-data
Ongoing 2015-005140-33 Can Fat Derived Stem Cells (SVF) be Used in the Treatment of Erectile Dysfunction After Prostatectomy- randomized, placebo-controlled, double-blind clinical trial. not-yet-due
Ongoing 2016-001591-30 Treatment of congenital nephrogenic diabetes insipidus not-yet-due
Ongoing 2016-002015-17 Low-flow Low-gradient Aortic Stenosis – Diagnostic Usefullness of Ivabradine not-yet-due
Completed, report not yet due 2016-002081-31 Investigation of dose response relationships when using low dose naltrexone (LDN) for the treatment of fibromyalgia 2018-09-10 not-yet-due
Not reported 2016-002237-30 Optimizing Colon Capsule Endoscopy in follow up program on patients with colorectal polyps assessing three booster procedures for motility enhancement 2017-09-30 due-trials
Ongoing 2016-004123-23 Immunization of immunosuppressed patients – Knowledge, practices and serological response not-yet-due
Ongoing 2016-004506-34 The effect of myoinositol (MI) or metformin treatment on symptoms of polycystisk ovary syndrome (PCOS), including metabolism, menstrual pattern, quality of life and mental health. not-yet-due
Ongoing 2016-005241-23 Lonsurf - RII not-yet-due
Ongoing 2017-001844-36 MethylphenIdate for fatigue in haematological cancer. A randomized, double-blind, placebo-controlled, CROssover trial - the MICRO trial not-yet-due
Ongoing 2017-002637-37 Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in resected high risk colon cancer patients. - The PIPAC-OPC3 CC trial - not-yet-due
Ongoing 2017-003627-30 Protection from food induced anaphylaxis by reducing serum level of specific IgE not-yet-due
Ongoing 2017-003775-62 FOLFIRINOX followed by local therapy (resection, RT and/or IRE) in patients with locally advanced pancreatic cancer (LAPC). A Nordic phase II study. not-yet-due
Ongoing 2017-004031-37 A multicentre, single-arm, phase II study to investigate the safety and antiemetic efficacy of Akynzeo® (a fixed dose combination of palonosetron and netupitant) plus dexamethasone in patients receivi... not-yet-due
Ongoing 2017-005179-21 Four weeks treatment for chronic hepatitis C in patients under 50 years of age with no significant liver fibrosis not-yet-due
Ongoing 2018-003416-50 Prevention of breast cancer-related lymphedema with tacrolimus not-yet-due